PHARMACEUTICAL BIOCHEMISTRY
cod. 23806

Academic year 2019/20
1° year of course - First semester
Professor
- Serena FAGGIANO
Academic discipline
Biochimica (BIO/10)
Field
Discipline biotecnologiche comuni
Type of training activity
Characterising
42 hours
of face-to-face activities
6 credits
hub: PARMA
course unit
in ITALIAN

Integrated course unit module: INTERACTION DRUG-BIOMOLECULES

Learning objectives

At the end of the course the students should demonstrate the understanding of the molecular basis of drug interaction with their biological targets. In detail, the student should be able to:
1) describe the biological function and mechanism of action of the main drug targets (KNOWLEDGE AND UNDERSTANDING)
2) describe from a molecular point of view how drug-target interaction can interfere with the biological function of the target and thus modify the biological state of the cell (KNOWLEDGE AND UNDERSTANDING)
3) identify correlations in the mechanism of action of different drug targets and establish connections between the mode of action of different ligands / inhibitors / agonists / antagonists (APPLYING KNOWLEDGE AND UNDERSTANDING)
4) explain the topics the course effectively with a language that uses appropriate scientific terminology (COMMUNICATION AND LEARNING SKILLS)

Prerequisites

Students should have a basic knowledge of Biochemistry, especially on the structure-activity relationship of proteins and on the mechanism of action of enzymes.

Course unit content

Definition of drug and drug target.
Binding properties of proteins.
Receptors as drug target.
Membrane transporters as drug target.
Enzymes as drug target.
Treatment of HIV and NSAIDs as examples of the therapeutic use of enzyme inhibitors.
Recombinant drugs.

Full programme

• Drug and drug target: definition

• Binding properties of proteins

• Receptors as drug target:
• Intracellular receptors
• GPCRs
• Receptor tyrosine kinases
• Tyr kinase-associated receptors
• Receptor guanylyl cyclases

• Membrane transporters as drug target

• Enzyme inhibition and drug discovery:
• Enzymes as drug targets
• Enzymatic catalysis
• Reversible inhibitors
• Irreversible inhibitors
• Tight-binding and slow-binding inhibitors
• NSAIDs
• Enzyme inhibition in HIV therapy

• Recombinant drugs and systems for their production

Bibliography

Selected scientific papers and copy of slides can be downloaded from the Elly
website.

David L. Nelson, Michael M. Cox
I PRINCIPI DI BIOCHIMICA DI LEHNINGER 7 ed, ZANICHELLI. (7th Edition)

Lodish H.
Biologia Molecolare della Cellula
3 ed italiana, Zanichelli (6th Edition)

Copeland R. Evaluation of enzyme inhibition in drug discovery, Wiley.

Patrick G.L.
Introduzione alla Chimica Farmaceutica, Ed. EdiSES

Teaching methods

Oral lessons integrated with informatic tools and the support of multimedia

Assessment methods and criteria

During the course 2 written tests (pre-appelli) are planned. If the result is positive for both tests, the exam will be passed, with a mark that will be the average of the two marks. Alternatively, an oral exam will be carried out during the regular exam sessions together with the exam of the module Chimica Fisica Biologica.

The written tests (pre-appelli) will be composed of multiple-choice questions and open questions.
If the final mark will be positive (at least 18/30), the mark will be averaged with the mark of the module Chimica Fisica Biologica to determine the final mark of the exam Interazione Farmaco-Biomolecole.

Other information

- - -